|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-5-25
|
|
pubmed:abstractText |
To evaluate effects on bone mineral density (BMD), safety, and tolerability of a single daily dose of alendronate (10 mg), administered for 1 year to postmenopausal women with osteoporosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0378-5122
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
30
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
35-44
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10091203-Administration, Oral,
pubmed-meshheading:10091203-Aged,
pubmed-meshheading:10091203-Aged, 80 and over,
pubmed-meshheading:10091203-Alendronate,
pubmed-meshheading:10091203-Analysis of Variance,
pubmed-meshheading:10091203-Bone Density,
pubmed-meshheading:10091203-Diphosphonates,
pubmed-meshheading:10091203-Europe,
pubmed-meshheading:10091203-Female,
pubmed-meshheading:10091203-Humans,
pubmed-meshheading:10091203-Middle Aged,
pubmed-meshheading:10091203-Osteoporosis, Postmenopausal,
pubmed-meshheading:10091203-Treatment Outcome,
pubmed-meshheading:10091203-United States
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Placebo-controlled multicenter study of oral alendronate in postmenopausal osteoporotic women. FOSIT-Study-Group. Fosamax International Trial.
|
|
pubmed:affiliation |
Department of Radiology, University Hospital Benjamin Franklin, Free University Berlin, Germany. felsenberg@ukbf.fu-berlin.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
